Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICTORIA
2024-516725-31-00Phase 2Authorised
- Sponsor
- Centre Léon Bérard
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in endometrial adenocarcinoma comparing AZD2014 + anastrozole with anastrozole alone (2 arms). Planned start Nov 2024; status: authorised.
02
Drugs
vistusertibanastrozole
03
Conditions
endometrial adenocarcinoma
Beyond the preview
Go deeper on 2024-516725-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516725-31-00.